Patent intelligence Β· CN
CN 119365549
Fluorescent probe targeting CA-IX
Fluorescent probe targeting CA-IX
Patent details β CN 119365549
- Jurisdiction
- CN
- Status
- granted
- Grant date
- Jan 24, 2025
- Expiration
- Jan 19, 2045
- Applicant
- BRACCO IMAGING SPA
- CPC classes
- A61K 49/ 00 A I, A61K/490032, A61K/490052
Quick answer
CN 119365549 (Fluorescent probe targeting CA-IX) is held by BRACCO IMAGING SPA. Status: granted. Granted Jan 24, 2025. Expires Jan 19, 2045 (19 years remaining) β relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- BRACCO IMAGING SPA
- Grant date
- Expiration
- Claims
- β
- CPC classes
- A61K 49/ 00 A I, A61K/490032, A61K/490052
More from BRACCO IMAGING SPA
Related pharmaceutical patents in our USPTO index.
-
CN 119343336
1, 4-bis-(2-hydroxy-benzyl)-1, 4, 7-triazacyclononane derivatives and similar compounds as ligands in iron (iii) complexes for use as MRI contrast agents
granted -
CN 119325492
Fluorescent probe targeting CA-IX
granted -
CN 118401500
Process for preparing mixtures of dimeric macrocyclic intermediates comprising gadolinium complexes
granted -
US 2024131199
PH RESPONSIVE CYANINE DYES AND CONJUGATES THEREOF
granted -
KR 20240034693
μ΄λ체 μ‘°μμ μ μ μ‘°
granted -
US 2023312523
NEAR-INFRARED CYANINE DYES AND CONJUGATES THEREOF
granted -
KR 20230116805
κ°λν 리λ μ μ‘°λ₯Ό μν μ μ‘° λ°©λ²
granted
Frequently asked questions
What is US patent 119365549?
CN 119365549 (Fluorescent probe targeting CA-IX) is held by BRACCO IMAGING SPA. Status: granted. Granted Jan 24, 2025. Expires Jan 19, 2045 (19 years remaining) β relevant for patent-cliff and LOE planning.
Who owns CN 119365549?
BRACCO IMAGING SPA is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 25 pharmaceutical patents for this assignee.
When does CN 119365549 expire?
Our index shows an expiration date of Jan 19, 2045 (19 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.